These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14990984)

  • 21. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
    Yoshimi A; Niemeyer CM; Bohmer V; Duffner U; Strahm B; Kreyenberg H; Dilloo D; Zintl F; Claviez A; Wössmann W; Kremens B; Holter W; Niethammer D; Beck JF; Kontny U; Nöllke P; Klingebiel T; Bader P
    Br J Haematol; 2005 May; 129(4):542-9. PubMed ID: 15877738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies.
    Horn B; Soni S; Khan S; Petrovic A; Breslin N; Cowan M; Pelle-Day G; Cooperstein E; Baxter-Lowe LA
    Bone Marrow Transplant; 2009 Mar; 43(6):469-76. PubMed ID: 18955982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms.
    Jiménez-Velasco A; Barrios M; Román-Gómez J; Navarro G; Buño I; Castillejo JA; Rodríguez AI; García-Gemar G; Torres A; Heiniger AI
    Leukemia; 2005 Mar; 19(3):336-43. PubMed ID: 15674363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia.
    Sramkova L; Muzikova K; Fronkova E; Krejci O; Sedlacek P; Formankova R; Mejstrikova E; Stary J; Trka J
    Pediatr Blood Cancer; 2007 Jan; 48(1):93-100. PubMed ID: 16521130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state aml after allogeneic stem cell transplantation.
    Hartwig M; Weigel S; Bernig T; Bader P; Dölken R; Beck J
    Pediatr Hematol Oncol; 2007 Mar; 24(2):137-40. PubMed ID: 17454780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders.
    Ozyurek E; Cowan MJ; Koerper MA; Baxter-Lowe LA; Dvorak CC; Horn BN
    Bone Marrow Transplant; 2008 Jul; 42(2):83-91. PubMed ID: 18391990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism.
    Svenberg P; Mattsson J; Ringdén O; Uzunel M
    Bone Marrow Transplant; 2009 Dec; 44(11):757-63. PubMed ID: 19421178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients.
    Pérez A; González-Vicent M; Ramirez M; Sevilla J; Madero L; Díaz MA
    Br J Haematol; 2008 Feb; 140(3):340-3. PubMed ID: 18053071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia.
    Ishaqi MK; Afzal S; Dupuis A; Doyle J; Gassas A
    Bone Marrow Transplant; 2008 Feb; 41(3):245-52. PubMed ID: 17952129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of donor lymphocyte infusions in thalassemia patients at imminent risk of graft rejection following stem cell transplantation.
    Karasu GT; Yesilipek MA; Karauzum SB; Uygun V; Manguoglu E; Kupesiz A; Hazar V
    Pediatr Blood Cancer; 2012 Mar; 58(3):453-8. PubMed ID: 21990066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
    Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
    Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
    Chiorean EG; DeFor TE; Weisdorf DJ; Blazar BR; McGlave PB; Burns LJ; Brown C; Miller JS
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):171-7. PubMed ID: 14993882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FISH detection of chimerism in pediatric hematopoietic stem cell transplantation.
    Aydin F; Oguz F; Onal AE; Bilgen H; Oguz R; Anak S; Carin M; Gedikoglu G
    Int J Lab Hematol; 2007 Jun; 29(3):208-14. PubMed ID: 17474899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.